发明公开
EP1861424A2 HUMAN MONOCLONAL ANTIBODIES AGAINST HENDRA AND PIPAH VIRUSES
有权
HUMANE MONOKLONALEANTIKÖRPERGEGEN HENDRA UND NIPAH-VIREN
- 专利标题： HUMAN MONOCLONAL ANTIBODIES AGAINST HENDRA AND PIPAH VIRUSES
- 专利标题（中）： HUMANE MONOKLONALEANTIKÖRPERGEGEN HENDRA UND NIPAH-VIREN
-
申请号： EP05858301.4申请日： 2005-11-04
-
公开(公告)号： EP1861424A2公开(公告)日： 2007-12-05
- 发明人: DIMITROV, Diviter, S. , ZHONGYU, Zhu , BRODER, Christopher, C.
- 申请人： The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services
- 申请人地址： National Institutes of Health Office of Technology Transfer Suite 325, 6011 Executive Boulevard Rockville, MD 20852-3804 US
- 专利权人： The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services
- 当前专利权人： The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services
- 当前专利权人地址： National Institutes of Health Office of Technology Transfer Suite 325, 6011 Executive Boulevard Rockville, MD 20852-3804 US
- 代理机构： Maschio, Antonio
- 优先权： US661766P 20050314; US678547P 20050505; US718902P 20050920
- 国际公布： WO2006137931 20061228
- 主分类号： C07K16/10
- IPC分类号： C07K16/10 ; A61K39/395
摘要：
The present invention relates to monoclonal antibodies that bind or neutralize Hendra or Nipah virus. The invention provides such antibodies, fragments of such antibodies retaining Hendra or Nipah virus-binding ability, fully human antibodies retaining Hendra or Nipah virus-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.
公开/授权文献
- EP1861424B1 HUMAN MONOCLONAL ANTIBODIES AGAINST HENDRA AND NIPAH VIRUSES 公开/授权日：2011-03-30
信息查询
